Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial nephrectomy for tumour.

A Puigvert1, A Serés, V Botella

  • 1Instituto de Urologia, Fundacion Puigvert, Hospital de la Santa Cruz y San Pablo, Barcelona, Spain.

International Urology and Nephrology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contingent screening for Down syndrome completed in the first trimester: a multicenter study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2007
Same author

Comparative mapping between Medicago sativa and Pisum sativum.

Molecular genetics and genomics : MGG·2004
Same author

Clinical experience with apomorphine hydrochloride: the first 107 patients.

The Journal of urology·2003
Same author

A new report of mesomelic camptomelia, polydactyly and Dandy-Walker complex in siblings.

Prenatal diagnosis·2003
Same author

Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis.

European journal of neurology·2001
Same journal

Does WHO/ISUP grade IV histology provide prognostic insight in chromophobe renal cell carcinoma?

International urology and nephrology·2026
Same journal

Age-stratified association between blood pressure and clinical outcomes in maintenance hemodialysis patients.

International urology and nephrology·2026
Same journal

Management and implementation of intermittent catheterisation in neurogenic lower urinary tract dysfunction: a clinical practice guideline in Germany - update 3.0.

International urology and nephrology·2026
Same journal

Medical expulsive therapies for ureteric stones: an umbrella review of network meta-analyses with novel evidence grading.

International urology and nephrology·2026
Same journal

Associations between PM2.5 exposure and upper tract urothelial carcinoma in a taiwanese case-control study.

International urology and nephrology·2026
Same journal

APRIL-targeted and dual BAFF/APRIL blockade in primary IgA nephropathy: a systematic review and meta-analysis of randomized placebo-controlled trials.

International urology and nephrology·2026
See all related articles

Partial nephrectomy for malignant renal tumors offers excellent long-term survival, with over 10-year survival rates indicating a potential cure for neoplastic disease. This conservative approach is effective for kidney tumor treatment.

Area of Science:

  • Urology
  • Oncology
  • Surgical Pathology

Background:

  • Malignant renal tumors pose a significant clinical challenge.
  • Partial nephrectomy is a conservative surgical option for kidney tumors.
  • Assessing long-term outcomes of this nephron-sparing approach is crucial.

Purpose of the Study:

  • To evaluate the efficacy of partial nephrectomy for malignant renal tumors.
  • To analyze indications, surgical techniques, and patient survival.
  • To determine the timeframe for considering neoplastic disease cured after treatment.

Main Methods:

  • Retrospective analysis of 33 cases undergoing partial nephrectomy for malignant renal tumors.
  • Review of surgical procedures and patient follow-up data.

Related Experiment Videos

  • Assessment of survival rates, particularly beyond 10 years.

    • Main Results:

    • Demonstrated successful outcomes in 33 cases of malignant renal tumor treated with partial nephrectomy.
    • Detailed presentation of indications and surgical techniques employed.
    • Significant survival rates beyond 10 years were observed, suggesting long-term efficacy.

    Conclusions:

    • Partial nephrectomy is a viable and effective treatment for malignant renal tumors.
    • Long-term survival data supports the conservative management of kidney cancer.
    • The study provides insights into the curability period for neoplastic disease post-surgery.